Credit Agricole’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,664
Closed -$229K 1311
2026
Q1
$229K Buy
+8,664
New +$254K ﹤0.01% 1250
2025
Q1
$970K Buy
46,716
+19,894
+74% +$500K ﹤0.01% 917
2024
Q4
$632K Buy
26,822
+6,876
+34% +$169K ﹤0.01% 1026
2024
Q3
$511K Buy
+19,946
New +$508K ﹤0.01% 944

Other funds holding ARKG

Credit Agricole's ARKG Position: Q2 2026 in Review

Credit Agricole sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 8,664 shares — an estimated $229K sold.

Credit Agricole first reported a position in ARKG in Q3 2024 and held it in 4 quarters. The position peaked at $970K in Q1 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Credit Agricole reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Credit Agricole sold 8,664 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $229K.
  • Credit Agricole first reported a position in ARK Genomic Revolution ETF in Q3 2024 and held it in 4 quarters.
  • Credit Agricole's ARK Genomic Revolution ETF position peaked at $970K in Q1 2025.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.